These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
174 related articles for article (PubMed ID: 8695058)
1. Short and long-term changes in cerebral [14C]-2-deoxyglucose uptake in the MPTP-treated marmoset: relationship to locomotor activity. Gnanalingham KK; Milkowski NA; Smith LA; Hunter AJ; Jenner P; Marsden CD J Neural Transm Gen Sect; 1995; 101(1-3):65-82. PubMed ID: 8695058 [TBL] [Abstract][Full Text] [Related]
2. Short- and long-term changes in striatal and extrastriatal dopamine uptake sites in the MPTP-treated common marmoset. Gnanalingham KK; Milkowski NA; Smith LA; Hunter AJ; Jenner P; Marsden CD Eur J Pharmacol; 1995 Apr; 277(2-3):235-41. PubMed ID: 7493614 [TBL] [Abstract][Full Text] [Related]
3. Alterations in striatal and extrastriatal D-1 and D-2 dopamine receptors in the MPTP-treated common marmoset: an autoradiographic study. Gnanalingham KK; Smith LA; Hunter AJ; Jenner P; Marsden CD Synapse; 1993 Jun; 14(2):184-94. PubMed ID: 8332947 [TBL] [Abstract][Full Text] [Related]
4. Regional (14C) 2-deoxyglucose uptake during vibrissae movements evoked by rat motor cortex stimulation. Sharp FR; Evans K J Comp Neurol; 1982 Jul; 208(3):255-87. PubMed ID: 7119161 [TBL] [Abstract][Full Text] [Related]
5. The role of striatopallidal neurones utilizing gamma-aminobutyric acid in the pathophysiology of MPTP-induced parkinsonism in the primate: evidence from [3H]flunitrazepam autoradiography. Robertson RG; Clarke CA; Boyce S; Sambrook MA; Crossman AR Brain Res; 1990 Oct; 531(1-2):95-104. PubMed ID: 2289139 [TBL] [Abstract][Full Text] [Related]
6. Chronic administration of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine to monkeys: behavioural, morphological and biochemical correlates. Albanese A; Granata R; Gregori B; Piccardi MP; Colosimo C; Tonali P Neuroscience; 1993 Aug; 55(3):823-32. PubMed ID: 8105418 [TBL] [Abstract][Full Text] [Related]
7. Monoamine oxidase-inhibition and MPTP-induced neurotoxicity in the non-human primate: comparison of rasagiline (TVP 1012) with selegiline. Kupsch A; Sautter J; Götz ME; Breithaupt W; Schwarz J; Youdim MB; Riederer P; Gerlach M; Oertel WH J Neural Transm (Vienna); 2001; 108(8-9):985-1009. PubMed ID: 11716151 [TBL] [Abstract][Full Text] [Related]
8. Regional brain uptake of 2-deoxyglucose in N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-induced parkinsonism in the macaque monkey. Crossman AR; Mitchell IJ; Sambrook MA Neuropharmacology; 1985 Jun; 24(6):587-91. PubMed ID: 3875056 [TBL] [Abstract][Full Text] [Related]
9. The primate subthalamic nucleus. II. Neuronal activity in the MPTP model of parkinsonism. Bergman H; Wichmann T; Karmon B; DeLong MR J Neurophysiol; 1994 Aug; 72(2):507-20. PubMed ID: 7983515 [TBL] [Abstract][Full Text] [Related]
10. Motor activity following the administration of selective D-1 and D-2 dopaminergic drugs to MPTP-treated common marmosets. Löschmann PA; Smith LA; Lange KW; Jähnig P; Jenner P; Marsden CD Psychopharmacology (Berl); 1992; 109(1-2):49-56. PubMed ID: 1365671 [TBL] [Abstract][Full Text] [Related]
11. Terguride stimulates locomotor activity at 2 months but not 10 months after 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine treatment of common marmosets. Lange KW; Löschmann PA; Wachtel H; Horowski R; Jähnig P; Jenner P; Marsden CD Eur J Pharmacol; 1992 Mar; 212(2-3):247-52. PubMed ID: 1350996 [TBL] [Abstract][Full Text] [Related]
12. Alterations in m-RNA expression for Cu,Zn-superoxide dismutase and glutathione peroxidase in the basal ganglia of MPTP-treated marmosets and patients with Parkinson's disease. Kunikowska G; Jenner P Brain Res; 2003 Apr; 968(2):206-18. PubMed ID: 12663090 [TBL] [Abstract][Full Text] [Related]
13. Striatal dopaminergic correlates of stable parkinsonism and degree of recovery in old-world primates one year after MPTP treatment. Elsworth JD; Taylor JR; Sladek JR; Collier TJ; Redmond DE; Roth RH Neuroscience; 2000; 95(2):399-408. PubMed ID: 10658619 [TBL] [Abstract][Full Text] [Related]
14. Acute MPTP treatment produces no changes in mitochondrial complex activities and indices of oxidative damage in the common marmoset ex vivo one week after exposure to the toxin. Gerlach M; Götz M; Dirr A; Kupsch A; Janetzky B; Oertel W; Sautter J; Schwarz J; Reichmann H; Riederer P Neurochem Int; 1996 Jan; 28(1):41-9. PubMed ID: 8746763 [TBL] [Abstract][Full Text] [Related]
15. Progression and recovery of Parkinsonism in a chronic progressive MPTP-induction model in the marmoset without persistent molecular and cellular damage. Franke SK; van Kesteren RE; Wubben JA; Hofman S; Paliukhovich I; van der Schors RC; van Nierop P; Smit AB; Philippens IH Neuroscience; 2016 Jan; 312():247-59. PubMed ID: 26431624 [TBL] [Abstract][Full Text] [Related]
16. 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced neurotoxicity in non-human primates is antagonized by pretreatment with nimodipine at the nigral, but not at the striatal level. Kupsch A; Sautter J; Schwarz J; Riederer P; Gerlach M; Oertel WH Brain Res; 1996 Nov; 741(1-2):185-96. PubMed ID: 9001722 [TBL] [Abstract][Full Text] [Related]
17. Nitric oxide synthase inhibition and MPTP-induced toxicity in the common marmoset. Mackenzie GM; Jackson MJ; Jenner P; Marsden CD Synapse; 1997 Jul; 26(3):301-16. PubMed ID: 9183819 [TBL] [Abstract][Full Text] [Related]
18. Transient depletion of nucleus accumbens dopamine content may contribute to initial akinesia induced by MPTP in common marmosets. Rose S; Nomoto M; Jenner P; Marsden CD Biochem Pharmacol; 1989 Nov; 38(21):3677-81. PubMed ID: 2597167 [TBL] [Abstract][Full Text] [Related]
19. The primate subthalamic nucleus. III. Changes in motor behavior and neuronal activity in the internal pallidum induced by subthalamic inactivation in the MPTP model of parkinsonism. Wichmann T; Bergman H; DeLong MR J Neurophysiol; 1994 Aug; 72(2):521-30. PubMed ID: 7983516 [TBL] [Abstract][Full Text] [Related]
20. Transdermal administration of piribedil reverses MPTP-induced motor deficits in the common marmoset. Smith LA; Jackson MG; Bonhomme C; Chezaubernard C; Pearce RK; Jenner P Clin Neuropharmacol; 2000; 23(3):133-42. PubMed ID: 10895396 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]